Skip to main content

Table 2 Pain measurement variables (stage analysis)

From: Efficacy of interrupted cyclic treatment with prednisolone on cancer pain: a randomized crossover study

Variable

Basal

14 days

P value

28 days

P value

VAS

     

Stage (A)-Glucocorticoid every 2nd day

4.49 ± 1.02

3.31 ± 0.83

≤ 0.001

3.1 ± 0.64

≤ 0.001

Stage (B)-Glucocorticoid every 4th day

3.59 ± 0.68

3.58 ± 0.55

0.453

3.74 ± 0.5.9

0.507

Pain severity score(PSS)

     

Stage (A)-Glucocorticoid every 2nd day

4.56 ± 0.75

3.7 ± 0.67

≤ 0.001

3.46 ± 0.52

≤ 0.001

Stage (B)-Glucocorticoid every 4th day

3.54 ± 0.38

3.54 ± 0. 43

0.678

3.62 ± 0.34

0.354

Pain interference score(PIS)

     

Stage (A)-Glucocorticoid every 2nd day

5.98 ± 1.58

5.26 ± 1.59

0.449

5.27 ± 1.43

0.213

Stage (B)-Glucocorticoid every 4th day

5.48 ± 1.36

5.38 ± 1.39

0.223

5.36 ± 1.39

0.663

Pain level score (PLS)

     

Stage (A)-Glucocorticoid every 2nd day

1.1 ± 0.307

1.1 ± 0.22

0.395

1.1 ± 0.38

0.432

Stage (B)-Glucocorticoid every 4th day

1.1 ± 0.35

1.2 ± 0.54

0.383

1.2 ± 0.54

0.383

Analgesia level score(ALS)

     

Stage (A)-Glucocorticoid every 2nd day

2.13 ± 0.34

2.13 ± 0.34

1

2.13 ± 0.34

1

Stage (B)-Glucocorticoid every 4th day

2.13 ± 0.34

2.13 ± 0.34

1

2.13 ± 0.34

1

Pain management index (PMI)

     

Stage (A)-Glucocorticoid every 2nd day

1.1 ± 0.35

1.1 ± 0.42

0.777

1.1 ± 0.46

0.572

Stage (B)-Glucocorticoid every 4th day

1.1 ± 0.51

1 ± 0.65

0.672

1 ± 0.65

0.672

  1. Legend: this table shows significant decrease in VAS and PSSC after 14 days and 28 days compared to basal values after oral glucocorticoid dosing once a day every other day as adjuvant to WHO stepladder analgesics with no significant difference as regards PIS, PLS, ALS, and PMI. Data were in mean and standard deviation. Cross tab chi-square statistical test was used for comparison of non-parametric data and t test for parametric data. P value was significant if < 0.05. Linear regression analysis for prediction of VAS score 28 indicated that 21.6% of VAS score day 28 can be predicted by dose of 10mg given every 2 days (stage A) [R2 = 0.216, F = 20.98, p Ë‚ 0.001]